Mesothelin Expression in Patients With High-Grade Serous Ovarian Cancer Does Not Predict Clinical Outcome but Correlates With CD11c+ Expression in Tumor
posted on 2020-10-09, 11:47authored byIsabelle Magalhaes, Josefin Fernebro, Sulaf Abd Own, Daria Glaessgen, Sara Corvigno, Mats Remberger, Jonas Mattsson, Hanna Dahlstrand
The above summary slide represents the opinions of
the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite).